ARENA PHARMACEUTICALS INC

(NASDAQ: ARNA)
  • Trade now
  • Add to Watchlist
  • Get Chart
  • Print report
6.18 Down -0.12 -1.90%
Find financial results for:
 Annual  Interim
2013 Q4 2013 Q3 2013 Q2 2013 Q1 2012 Q4
Period End Date 12/31/2013 09/30/2013 06/30/2013 03/31/2013 12/31/2012
Stmt Source N/A N/A N/A N/A N/A
Stmt Source Date 12/31/2013 09/30/2013 06/30/2013 03/31/2013 12/31/2012
Stmt Update Type Original Original Original Original Original
Currency Code USD USD USD USD USD
 
Assets
Cash, Equiv and Short Term Investments
221.9 180.7 178.9 136.3 156.1
Cash and Cash Equivalents 221.9 180.7 178.9 136.3 156.1
Receivables
10.6 12.4 1.1 1.5 5.6
Accounts Receivable 10.6 12.4 1.1 1.5 5.6
Inventories
12.8 10.0 7.2 7.2 6.1
Finished Goods 8.0 7.7 4.8 4.4 1.5
Raw Materials 0.7 0.6 0.4 0.5 0.4
Work-in-Process 4.1 1.7 2.0 2.3 4.2
Prepaid Assets and Others 3.6 3.4 3.2 3.8 3.5
Total Current Assets 248.8 206.6 190.4 148.7 171.2
 
Net Property,Plant,and Equipment
77.4 74.5 73.9 73.9 75.4
Gross Property,Plant,and Equipment
165.4 0.0 0.0 0.0 159.3
Land and Improvements 10.9 0.0 0.0 0.0 10.9
Buildings and Improvements 67.7 0.0 0.0 0.0 67.4
Machinery,Furniture/Equipment 68.9 0.0 0.0 0.0 61.8
Leasehold and Improvements 17.9 0.0 0.0 0.0 19.3
Accumulated Depreciation -88.0 0.0 0.0 0.0 -83.9
Goodwill and Other Intangible Assets
10.2 10.2 9.9 10.1 10.6
Other Intangible Assets 10.2 0.0 0.0 0.0 10.6
Other Non-Current Assets 3.4 3.4 3.7 4.1 4.0
Total Non-Current Assets 91.0 88.1 87.5 88.0 90.0
 
Total Assets 339.8 294.7 278.0 236.7 261.2
           
Liabilities and Shareholders' Equity
Payables
23.0 21.7 8.9 2.5 3.9
Accounts Payable 3.7 3.0 2.5 2.5 3.9
Other Payable 19.3 18.7 6.3 0.0 0.0
Accrued Expenses,Current 7.2 6.9 7.7 5.9 5.8
Provisions,Current 0.6 0.0 0.3 0.7 0.5
Current Portion of Capital Lease Obligation 2.1 2.0 1.9 1.8 1.7
Deferred Liabilities,Current
37.9 29.2 7.8 15.4 15.5
Deferred Revenue,Current 37.9 29.2 7.8 15.4 15.5
Other Current Liabilities 0.0 0.0 0.0 1.0 2.6
Total Current Liabilities 70.7 59.8 26.6 27.2 29.9
           
LT Debt and Capital Lease Obligation
70.7 71.3 71.8 72.3 72.8
Long Term Portion of Capital Lease Obligation 70.7 71.3 71.8 72.3 72.8
Deferred Liabilities, Non current
101.6 46.6 45.6 46.5 47.4
Deferred Revenues,Non-Current 101.3 46.4 45.4 46.3 47.3
Derivative Liabilities 4.9 4.9 9.0 10.2 12.5
Total Non-Current Liabilities and MI 177.2 122.8 126.4 129.0 132.7
           
Total Liabilities 248.0 182.6 153.0 156.2 162.6
           
Retained Earnings -1,207.7 -1,184.3 -1,167.1 -1,207.2 -1,188.3
Additional Paid in Capital 1,293.8 1,290.7 1,287.7 1,283.7 1,281.4
Accum Gains/ Losses Not Affecting RE 5.7 5.6 4.3 3.9 5.5
Total Equity 91.9 112.1 124.9 80.4 98.6
           
Total Liabilities and Equity 339.8 294.7 278.0 236.7 261.2
           
Ordinary Shares Outstanding 218.82 217.48 217.48 217.48 217.48
 

Financial data in USD
Values in Millions (Except for per share items)

Business Type: Industry

Financial statements are prepared in this standard format to allow direct comparisons of all companies and industries across multiple time frames.

See 10K and 10Q SEC Filings for as reported statements

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.